A multisite evaluation of machine learning classifiers to predict progression to mild cognitive impairment using multimodal imaging

Abstract

Background: Predicting progression to mild cognitive impairment (MCI) and dementia in preclinical AD patients is crucial for proper recruitment into anti‐amyloid clinical trials.